Organogenesis Holdings Inc. (ORGO)

USD 5.28

(6.45%)

Net Debt Summary of Organogenesis Holdings Inc.

  • Organogenesis Holdings Inc.'s latest annual net debt in 2023 was 15.01 Million USD , down -29.56% from previous year.
  • Organogenesis Holdings Inc.'s latest quarterly net debt in 2024 Q2 was 20.51 Million USD , down -14.54% from previous quarter.
  • Organogenesis Holdings Inc. reported annual net debt of 21.31 Million USD in 2022, up 16.0% from previous year.
  • Organogenesis Holdings Inc. reported annual net debt of 18.37 Million USD in 2021, up 4773.74% from previous year.
  • Organogenesis Holdings Inc. reported quarterly net debt of 26.87 Million USD for 2024 Q1, up 79.0% from previous quarter.
  • Organogenesis Holdings Inc. reported quarterly net debt of 15.01 Million USD for 2023 Q4, down -43.96% from previous quarter.

Annual Net Debt Chart of Organogenesis Holdings Inc. (2023 - 2015)

Historical Annual Net Debt of Organogenesis Holdings Inc. (2023 - 2015)

Year Net Debt Net Debt Growth
2023 15.01 Million USD -29.56%
2022 21.31 Million USD 16.0%
2021 18.37 Million USD 4773.74%
2020 377 Thousand USD -99.07%
2019 40.43 Million USD 6.48%
2018 37.97 Million USD 146785.47%
2017 -25.88 Thousand USD 97.51%
2016 -1.04 Million USD -2225.28%
2015 48.93 Thousand USD 0.0%

Peer Net Debt Comparison of Organogenesis Holdings Inc.

Name Net Debt Net Debt Difference
Esperion Therapeutics, Inc. 458.69 Million USD 96.727%
Theratechnologies Inc. 24.87 Million USD 39.637%
Safety Shot Inc -2.28 Million USD 757.204%
Cosmos Health Inc. 8.59 Million USD -74.758%
Cronos Group Inc. -663.32 Million USD 102.263%
Ironwood Pharmaceuticals, Inc. 623.38 Million USD 97.592%
Kala Pharmaceuticals, Inc. -14.57 Million USD 203.026%
Universe Pharmaceuticals INC 197.2 Thousand USD -7512.736%
ProPhase Labs, Inc. 19.23 Million USD 21.933%
Sonoma Pharmaceuticals, Inc. -2.52 Million USD 695.754%
Dynavax Technologies Corporation 106.63 Million USD 85.921%
Radius Health, Inc. 359.28 Million USD 95.821%
China SXT Pharmaceuticals, Inc. -9.42 Million USD 259.209%
Alvotech 1.06 Billion USD 98.589%
Sunshine Biopharma, Inc. -15.63 Million USD 196.024%
Alpha Teknova, Inc. 1.97 Million USD -660.537%
Intra-Cellular Therapies, Inc. -130.82 Million USD 111.475%
SCYNEXIS, Inc. -19.35 Million USD 177.587%
Harrow Health, Inc. 116.41 Million USD 87.104%
Biofrontera Inc. 4.05 Million USD -270.143%
DURECT Corporation -7.65 Million USD 296.146%
Supernus Pharmaceuticals, Inc. -33.52 Million USD 144.779%
ANI Pharmaceuticals, Inc. 94.2 Million USD 84.064%
OptiNose, Inc. 58.06 Million USD 74.144%
RedHill Biopharma Ltd. -5.18 Million USD 389.489%
Aquestive Therapeutics, Inc. 74.95 Million USD 79.969%
Cumberland Pharmaceuticals Inc. 106.85 Thousand USD -13949.355%
SIGA Technologies, Inc. -148.68 Million USD 110.097%
Lifecore Biomedical, Inc. 121.89 Million USD 87.684%
Shineco, Inc. 29.29 Million USD 48.744%
Phibro Animal Health Corporation 454.84 Million USD 96.699%
Procaps Group S.A. 242.93 Million USD 93.82%
TherapeuticsMD, Inc. 3.67 Million USD -308.184%
Regencell Bioscience Holdings Limited -2.9 Million USD 617.435%
Viatris Inc. 17.13 Billion USD 99.912%
Sunshine Biopharma, Inc. -15.63 Million USD 196.024%
Rockwell Medical, Inc. 4.45 Million USD -236.917%
Incannex Healthcare Limited -5.48 Million USD 373.71%
Aytu BioPharma, Inc. -4.87 Million USD 407.833%
Tilray Brands, Inc. 158.97 Million USD 90.556%
Collegium Pharmaceutical, Inc. 435.33 Million USD 96.551%
PetIQ, Inc. 351.93 Million USD 95.734%
Silver Spike Investment Corp. -32.61 Million USD 146.036%
Neurocrine Biosciences, Inc. 177.3 Million USD 91.532%
Journey Medical Corporation -9.7 Million USD 254.63%
Alimera Sciences, Inc. 55.3 Million USD 72.856%
Petros Pharmaceuticals, Inc. -5.06 Million USD 396.677%
Assertio Holdings, Inc. -32.52 Million USD 146.153%
Shuttle Pharmaceuticals Holdings, Inc. -1.48 Million USD 1108.449%
Embecta Corp. 1.31 Billion USD 98.856%
Cyclo Therapeutics, Inc. -8.21 Million USD 282.785%
Procaps Group, S.A. 242.93 Million USD 93.82%
PainReform Ltd. -7.95 Million USD 288.843%
Avadel Pharmaceuticals plc 4.21 Million USD -256.011%
Hempacco Co., Inc. 13.61 Million USD -10.271%
Talphera, Inc. -5.72 Million USD 362.419%
Pacira BioSciences, Inc. 432.74 Million USD 96.531%
Alvotech 1.06 Billion USD 98.589%
Lantheus Holdings, Inc. -96.71 Million USD 115.524%
Kamada Ltd. -46.43 Million USD 132.334%
Indivior PLC -33.95 Million USD 144.218%
Currenc Group, Inc. -16.57 Million USD 190.586%
Evoke Pharma, Inc. 260.57 Thousand USD -5661.511%
Flora Growth Corp. -713 Thousand USD 2205.61%
Cyclo Therapeutics, Inc. -8.21 Million USD 282.785%
Evolus, Inc. 63.7 Million USD 76.435%
HUTCHMED (China) Limited -197.45 Million USD 107.603%
Amphastar Pharmaceuticals, Inc. 479.11 Million USD 96.866%
Akanda Corp. 3.9 Million USD -284.464%